ADHD Clinical Trial
Official title:
Effects of Ongoing Movement-Based Mindfulness Training for Children With ADHD
Verified date | January 2024 |
Source | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Attention Deficit Hyperactivity Disorder (ADHD) has tremendous individual and societal impact, and the effectiveness of current standard treatments is limited. Thus, there are potential public health benefits for novel behavioral training programs that could remediate the core features of ADHD and contribute to sustained improvements in behavioral control. There is mounting evidence that children with ADHD show difficulties with motor control, and that these motor deficits are strongly associated with the core behavioral features of ADHD. Based on this information, the CNIR initiated a feasibility trial of a movement-based intervention, utilizing Tai Chi practice, targeting improved behavioral control through engagement of the motor system and results are highly promising. The investigators therefore will employ an extension of our ongoing Tai Chi programs for children with ADHD, beginning with children who have already completed one of the previous Tai Chi sessions. This program will provide the basis for studying the long-term effects of mindful movement, as well as creating a foundation for exploring the way that such interventions can be expanded into a more realistic support setting for the community. Hypothesis: After participating in the ongoing Tai Chi program, children with ADHD will show improvements in behavioral measures of motor, cognitive, and attentional control. The investigators further expect movement-based training will result in decreases in ADHD symptom severity.
Status | Active, not recruiting |
Enrollment | 50 |
Est. completion date | December 2024 |
Est. primary completion date | December 31, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 8 Years to 15 Years |
Eligibility | Inclusion Criteria: - Children must meet diagnostic criteria for ADHD, based on information from previous participation in "Movement-Based Mindfulness Training for Children with ADHD: A Feasibility Study." Additionally, children must meet criteria on the parent and teacher Conners-3 - Comorbid oppositional defiant disorder (ODD) and anxiety disorders are permitted - Stimulants, psychoactive medications, or no medication are allowed Exclusion Criteria: - diagnosis of Intellectual Disability, Developmental Language Disorder, Reading Disability, or Autism (screened for using the Social Competence Questionnaire (SCQ) - neurologic disorder (e.g., epilepsy, cerebral palsy, traumatic brain injury, Tourette Syndrome) - documented hearing impairment = 25 dB (decibel) loss in either ear. - a Full Scale IQ (Intelligence Quotient) score on the WISC-IV (Wechsler Intelligence Scale for Children) below 80 - a standard score below 85 on the Word Reading Subtest, regardless of IQ score - foster care - Female participants will be excluded if they are pregnant or may be pregnant |
Country | Name | City | State |
---|---|---|---|
United States | LEAP Facility at Kennedy Krieger Institute | Baltimore | Maryland |
Lead Sponsor | Collaborator |
---|---|
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cognitive Motor Control: Response inhibition | RDoC (research domain criteria) battery for cognitive control targeting response inhibition delivered via laboratory computer (Go/No-Go) examining percentage of error rate and successful inhibition. Significant improvements in response inhibition are expected over the course of the intervention. | From date of baseline and at every 6 months following, assessed up to 60 months. | |
Primary | Cognitive Motor Control: Response inhibition | RDoC (research domain criteria) battery for cognitive control targeting response inhibition delivered via laboratory computer (Flanker) examining percentage of error rate and successful inhibition. Significant improvements in response inhibition are expected over the course of the intervention. | From date of baseline and at every 6 months following, assessed up to 60 months. | |
Primary | Cognitive Motor Control: Response inhibition | RDoC (research domain criteria) battery for cognitive control targeting response inhibition delivered via laboratory computer (Stop-Signal) examining percentage of error rate and successful inhibition. Significant improvements in response inhibition are expected over the course of the intervention. | From date of baseline and at every 6 months following, assessed up to 60 months. | |
Primary | Cognitive Motor Control: Response inhibition | RDoC (research domain criteria) battery for cognitive control targeting response inhibition delivered via laboratory computer (Mirror Tracing Persistence Task) examining percentage of error rate and successful inhibition. Significant improvements in response inhibition are expected over the course of the intervention. | From date of baseline and at every 6 months following, assessed up to 60 months. | |
Primary | Cognitive Motor Control: Response inhibition | RDoC (research domain criteria) battery for cognitive control targeting response inhibition delivered via laboratory computer (DKEFS Trail Making Task) examining percentage of error rate and successful inhibition. Significant improvements in response inhibition are expected over the course of the intervention. | From date of baseline and at every 6 months following, assessed up to 60 months. | |
Primary | Behavioral Assessment of Motor Persistence | Measure of oculomotor persistence and inhibition using the Lateral Gaze Fixation task. Improvements in oculomotor persistence are expected over the course of the intervention. | From date of baseline and at every 6 months following, assessed up to 60 months. | |
Primary | Behavioral Assessment of Motor Persistence | Measure of motor persistence and inhibition using the NEPSY Statue Task ("A Developmental NEuroPSYchological Assessment"). Improvements in motor persistence are expected over the course of the intervention. | From date of baseline and at every 6 months following, assessed up to 60 months. | |
Primary | Behavioral Assessments of Motor Overflow | Measure of motor overflow from the PANESS (Physical and Neurologic Examination of Subtle Signs). Improvements in motor overflow are expected over the course of the intervention. | From date of baseline and at every 6 months following, assessed up to 60 months. | |
Primary | Behavioral Assessments of Basic Motor Control | Measure of motor control from the mABC-2 (Movement Assessment Battery for Children). Improvements in motor control are expected over the course of the intervention. | From date of baseline and at every 6 months following, assessed up to 60 months. | |
Primary | Clinical Measure of ADHD Symptom Severity | The Conners-3 survey (parent and teacher). Improvements on this measure are expected over the course of the intervention. In particular, based on previous findings from the CNIR initiated mindful movement feasibility study, marked improvements on Connors-3 subscales for Inattentiveness and Hyperactivity are expected. | From date of baseline and at every 6 months following, assessed up to 60 months. | |
Secondary | Clinical Measure of Mindfulness | The CAMM (Child and Adolescent Mindfulness Measure) will be administered. Improvements on this measure are expected over the course of the intervention. | From date of baseline and at every 6 months following, assessed up to 60 months. | |
Secondary | Clinical Measure of Quality of Life | The PedsQL (Pediatric Quality of Life Inventory) (parent and child) will be administered. Improvements on this measure are expected over the course of the intervention. | From date of baseline and at every 6 months following, assessed up to 60 months. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03148782 -
Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase
|
N/A | |
Recruiting |
NCT06038942 -
Formal Versus Informal Mindfulness Among University Students With Self-reported ADHD, Nonsuicidal Self-injury, or Stress
|
N/A | |
Not yet recruiting |
NCT06456372 -
Digital Health Intervention for Children With ADHD
|
N/A | |
Completed |
NCT05518435 -
Managing Young People With ADHD in Primary Care Study
|
||
Active, not recruiting |
NCT04978792 -
Does Cultivating Self-compassion Improve Resilience to Criticism and Improve Mental Health in Adults With ADHD?
|
N/A | |
Completed |
NCT03216512 -
Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD
|
N/A | |
Completed |
NCT02829528 -
Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention
|
N/A | |
Completed |
NCT02900144 -
Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)
|
N/A | |
Not yet recruiting |
NCT02906501 -
Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances
|
N/A | |
Completed |
NCT02562469 -
ACTIVATE: A Computerized Training Program for Children With ADHD
|
N/A | |
Terminated |
NCT02271880 -
Improving Medication Adherence in ADHD Adolescents
|
N/A | |
Recruiting |
NCT02255565 -
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
|
Phase 4 | |
Completed |
NCT02463396 -
Mindfulness Training in Adults With ADHD
|
N/A | |
Completed |
NCT01673594 -
Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist
|
Phase 4 | |
Terminated |
NCT01733680 -
Amiloride Hydrochloride as an Effective Treatment for ADHD
|
Early Phase 1 | |
Completed |
NCT02300597 -
Internet-based Support for Young People With ADHD and Autism - a Controlled Study
|
N/A | |
Active, not recruiting |
NCT01137318 -
Combined Cognitive Remediation and Behavioral Intervention for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)
|
Phase 2 | |
Completed |
NCT01404273 -
Functional MRI of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder
|
N/A | |
Completed |
NCT00586157 -
Study of Medication Patch to Treat Children Ages 6-12 With ADHD
|
Phase 4 | |
Completed |
NCT00573859 -
The Reinforcing Mechanisms of Smoking in Adult ADHD
|
Phase 1/Phase 2 |